Wound Healing

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2022-07-15
EMA Withdrawn: Episalvan (Betulae cortex) — Amryt AG
Episalvan (Betulae cortex) has been withdrawn from the market in the EMA process.